|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Endothelial dysfunction as a predictor of cardiovascular disease in type 1 diabetes显示文摘Macro and microvascular disease are the main cause of morbi-mortality in type 1 diabetes(T1DM).Although there is a clear association between endothelial dysfunction and atherosclerosis in type 2 diabetes,a cause-effect relationship is less clear in T1 DM.Although endothelial dysfunction(ED) precedes atherosclerosis,it is not clear weather,in recent onset T1 DM,it may progress to clinical macrovascular disease.Moreover,endothelial dysfunction may either be reversed spontaneously or in response to intensive glycemic control,long-term exercise training and use of statins.Acute,long-term and post-prandial hyperglycemia as well as duration of diabetes and microalbuminuria are all conditions associated with ED in T1 DM.The pathogenesis of endothelial dysfunction is closely related to oxidative-stress.NAD(P)H oxidase over activity induces excessive superoxide production inside the mitochondrial oxidative chain of endothelial cells,thus reducing nitric oxide bioavailability and resulting in peroxynitrite formation,a potent oxidant agent.Moreover,oxidative stress also uncouples endothelial nitric oxide synthase,which becomes dysfunctional,inducing formation of superoxide.Other important mechanisms are the activation of both the polyol and protein kinase C pathways as well as the presence of advanced glycation end-products.Future studies are needed to evaluate the potential clinical applicability of endothelial dysfunction as a marker for early vascular complications in T1 DM. | Marcello C Bertoluci Gislaine V Cé Antonio MV da Silva Marco V Wainstein Winston Boff Marcia Punales | 2015 | World Journal of Diabetes2015，6，5： | 5 |
| 2 | No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention显示文摘 | Frederic S. Resnic Marco Wainstein Michael K.Y. Lee Dominik Behrendt Rodrigo V. Wainstein Lucila Ohno-Machado James M. Kirshenbaum Campbell D.K. Rogers Jeffrey J. Popma Robert Piana | 2003 | American Heart Journal2003，，1： | 2 |
| 3 | Strain, strain rate and the force frequency relationship in patients with and without heart failure显示文摘 | Mak S Van Spall I-IG Wainstein RV | 2012 | J Am Soc Echocardiogr2012，25，3： | 1 |
| 4 | No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention显示文摘 | Resnic FS Wainstein M Lee MK | 2003 | Am Heart J2003，145，1： | 1 |
| 5 | Glycemic effects of moderate alcohol intake among patients with type 2 diabetes: a multicenter, randomized, clinical intervention trial 显示文摘 | Shai I Wainstein J Harman-Boehm I | 2007 | Diabetes Care2007，30，12： | 1 |
| 6 | No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention 显示文摘 | RESNIC F S WAINSTEIN M LEE M K | 2003 | AM Heart J2003，145，1： | 1 |
| 7 | No-reflow is an independent predictor ofdeath andmyocardial infarction after percutaneous coronary intervention显示文摘 | Resnic FS Wainstein MW Lee MK | 2003 | Am Heart J2003，145，： | 1 |
| 8 | Lack of clinical efficacy of pharmacologic treatment of the noreflow phenomenon despite significant angiographic improvement显示文摘 | Wainstein M Frederic F Lee M | 2001 | J Am Coll Cardiol2001，37，： | 1 |
| 9 | No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention显示文摘 | Resnic FS Wainstein M Lee MK | 2003 | Am Heart J2003，145，1： | 1 |
| 10 | No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention显示文摘 | Resnic FS Wainstein M Lee MK | 2003 | Am Heart J2003，145，： | 1 |
| 11 | No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention显示文摘 | Resnic FS Wainstein M Lee MK | 2003 | Am Heart J2003，145，2： | 1 |
| 12 | No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention显示文摘 | Resnic FS Wainstein M Lee MK | 2003 | Am Heart J2003，145，1： | 1 |
| 13 | No-reflow is an indepen- dent predictor of death and myocardial infarktion after percutaneous coronary intervention显示文摘 | Resnie FS Wainstein M Lee MK | 2003 | Am Heart J2003，145，： | 1 |
| 14 | No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention显示文摘 | Resnic FS Wainstein M Lee MK | 2003 | Am Heart J2003，145，1： | 1 |
| 15 | Clinical, socioeconomic,and lifestyle parameters associated with erectile dysfunction amongdiabetic men显示文摘 | Kalter-Leibovici 0 Wainstein J Ziv A | 2005 | Diabetes Care2005，28，7： | 1 |
| 16 | No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention 显示文摘 | Resnic FS Wainstein M Lee MKY | 2003 | Am Heart J2003，145，1： | 1 |
| 17 | Current indications for open stone surgery in the treatment of renal and ureteral calculi显示文摘 | Paik ML Wainstein MA Spirnak JP | 1998 | J Urol1998，159，： | 1 |
| 18 | The role of chromium in protective alumina scale formation during the oxidation of ternary TiA1Cr alloys in air显示文摘 | FOX-RABINOVICH G S WEATHERLY G C WILKINSON D S KOVALEV A I WAINSTEIN D L | 2004 | Intermetallics2004，12，2： | 1 |
| 19 | Treatment with rosiglitazone reduces hyperinsulinemia and improves arterial elasticity in patients with type 2 diabetes mellitus显示文摘 | Shargorodsky M Wainstein J Garish D | 2003 | Am J Hypertens2003，16，8： | 1 |
| 20 | Association between myeloperoxidase polymorphisms and its plasma levels with severity of coronary artery disease 显示文摘 | Wainstein R V Wainstein M V Ribeiro J P | 2010 | Clin Biochem2010，43，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员